263 related articles for article (PubMed ID: 27053690)
1. Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats.
Iseri K; Iyoda M; Ohtaki H; Matsumoto K; Wada Y; Suzuki T; Yamamoto Y; Saito T; Hihara K; Tachibana S; Honda K; Shibata T
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1182-91. PubMed ID: 27053690
[TBL] [Abstract][Full Text] [Related]
2. Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis.
Tsuda H; Yamahara K; Ishikane S; Otani K; Nakamura A; Sawai K; Ichimaru N; Sada M; Taguchi A; Hosoda H; Tsuji M; Kawachi H; Horio M; Isaka Y; Kangawa K; Takahara S; Ikeda T
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1004-13. PubMed ID: 20739390
[TBL] [Abstract][Full Text] [Related]
3. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis.
Suzuki T; Iyoda M; Shibata T; Ohtaki H; Matsumoto K; Shindo-Hirai Y; Kuno Y; Wada Y; Yamamoto Y; Kawaguchi M; Shioda S; Akizawa T
PLoS One; 2013; 8(6):e67475. PubMed ID: 23826305
[TBL] [Abstract][Full Text] [Related]
5. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
Aki K; Shimizu A; Masuda Y; Kuwahara N; Arai T; Ishikawa A; Fujita E; Mii A; Natori Y; Fukunaga Y; Fukuda Y
Am J Physiol Renal Physiol; 2010 Apr; 298(4):F870-82. PubMed ID: 20071465
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
[TBL] [Abstract][Full Text] [Related]
7. Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats.
Chen YM; Hu-Tsai MI; Lin SL; Tsai TJ; Hsieh BS
Nephrol Dial Transplant; 2003 Dec; 18(12):2505-14. PubMed ID: 14605272
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
[TBL] [Abstract][Full Text] [Related]
9. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
Elner VM; Burnstine MA; Strieter RM; Kunkel SL; Elner SG
Exp Eye Res; 1997 Dec; 65(6):781-9. PubMed ID: 9441701
[TBL] [Abstract][Full Text] [Related]
10. Production of monocyte chemoattractant protein-1 by bovine glomerular endothelial cells.
Kakizaki Y; Waga S; Sugimoto K; Tanaka H; Nukii K; Takeya M; Yoshimura T; Yokoyama M
Kidney Int; 1995 Dec; 48(6):1866-74. PubMed ID: 8587246
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis.
Stahl RA; Thaiss F; Disser M; Helmchen U; Hora K; Schlöndorff D
Kidney Int; 1993 Nov; 44(5):1036-47. PubMed ID: 8264133
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6.
Sheryanna A; Bhangal G; McDaid J; Smith J; Manning A; Foxwell BM; Feldmann M; Cook HT; Pusey CD; Tam FW
J Am Soc Nephrol; 2007 Apr; 18(4):1167-79. PubMed ID: 17314328
[TBL] [Abstract][Full Text] [Related]
13. Pre-activation of mesenchymal stem cells with TNF-α, IL-1β and nitric oxide enhances its paracrine effects on radiation-induced intestinal injury.
Chen H; Min XH; Wang QY; Leung FW; Shi L; Zhou Y; Yu T; Wang CM; An G; Sha WH; Chen QK
Sci Rep; 2015 Mar; 5():8718. PubMed ID: 25732721
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha.
Karkar AM; Smith J; Pusey CD
Nephrol Dial Transplant; 2001 Mar; 16(3):518-24. PubMed ID: 11239025
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
16. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
Kunter U; Rong S; Djuric Z; Boor P; Müller-Newen G; Yu D; Floege J
J Am Soc Nephrol; 2006 Aug; 17(8):2202-12. PubMed ID: 16790513
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD
Kidney Int; 1999 Apr; 55(4):1319-26. PubMed ID: 10200996
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors.
Rampino T; Gregorini M; Bedino G; Piotti G; Gabanti E; Ibatici A; Sessarego N; Piacenza C; Balenzano CT; Esposito P; Bosio F; Soccio G; Frassoni F; Dal Canton A
Clin Sci (Lond); 2011 Jan; 120(1):25-36. PubMed ID: 20583996
[TBL] [Abstract][Full Text] [Related]
19. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
[TBL] [Abstract][Full Text] [Related]
20. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
Urushihara M; Ohashi N; Miyata K; Satou R; Acres OW; Kobori H
Hypertension; 2011 Mar; 57(3):586-93. PubMed ID: 21282555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
